Iridex Gets Nasdaq Delisting Warning

Iridex, a maker of maker of semiconductor-based laser systems for the ophthalmology and dermatology markets, said Tuesday it received a Nasdaq delisting warning because it did not file its second-quarter results on time, according to the Associated Press. .
   The Mountain View, CA-basd company said it expected the notice and that it has requested a hearing before a Nasdaq panel, and will remain listed on the exchange at least until the panel renders a decision. .
   The filing was delayed pending the completion of an investigation by its board’s audit committee into the recognition of revenue from certain sales made in the fourth quarter of fiscal 2004. The company says it plans to file its quarterly report “as soon as practicable after the completion of the audit committee’s review and analysis.”